Atherogenic Dyslipidemia Patterns And Hypertension Severity In Type 2 Diabetes Mellitus: A Systematic Review And Meta-Analysis

Alif Nurfattah Hakim; Meidanty Gasa Nugraeni

doi:10.55227/ijhet.v5i2.1007

Authors

Alif Nurfattah Hakim a:1:{s:5:"en_US";s:133:"Medical Study Program, Faculty of Medicine and Health Sciences, Republic of Indonesia Defense University, Bogor, West Java, Indonesia";}
Meidanty Gasa Nugraeni Medical Study Program, Faculty of Medicine and Health Sciences, Republic of Indonesia Defense University, Bogor, West Java, Indonesia

DOI:

https://doi.org/10.55227/ijhet.v5i2.1007

Keywords:

Type 2 Diabetes Mellitus, Atherogenic Dyslipidemia, Hypertension Severity, Atherogenic Index of Plasma, Cardiovascular Risk.

Abstract

Atherogenic dyslipidemia and hypertension frequently co-occur in Type 2 Diabetes Mellitus (T2DM), yet the precise impact of composite lipid patterns on blood pressure severity requires comprehensive evaluation. This study conducted a systematic review of six observational studies encompassing over 7.6 million individuals to quantify this relationship. The quantitative synthesis demonstrated a highly significant positive association, revealing that patients with elevated atherogenic indices such as the Atherogenic Index of Plasma (AIP) or Lipoprotein Combined Index (LCI) that exhibited a 35% greater likelihood of experiencing severe, poorly controlled hypertension compared to those with normative profiles. Ultimately, atherogenic dyslipidemia acts as a significant, independent driver of hypertension severity. To optimize cardiovascular risk reduction, clinical management protocols for diabetic hypertension must evolve beyond isolated LDL-C targets to systematically address comprehensive atherogenic lipid profiles.

Downloads

Download data is not yet available.

References

Amadi, C. E., Mbakwem, A. C., Duro, D. C., Udenze, I. C., Akinsola, C. M., Ajuluchukwu, J. N., & Oke, D. A. W. (2022). Prevalence, patterns and predictors of metabolic abnormalities in Nigerian hypertensives with hypertriglyceridemic waist phenotype: A cross sectional study. PLOS Global Public Health, 2(12), Article e0001203. https://doi.org/10.1371/journal.pgph.0001203

Dalal, J., Chandra, P., Chawla, R., Kumar, V., Abdullakutty, J., Natarajan, V., Naqvi, S. M. H., Gaurav, K., Rathod, R., Dhanaki, G., Kotak, B., & Shah, S. (2024). Clinical and demographic characteristics of patients with coexistent hypertension, type 2 diabetes mellitus, and dyslipidemia: A retrospective study from India. Drugs - Real World Outcomes, 11, 167–176. https://doi.org/10.1007/s40801-023-00400-3

Goyal, R., Singhal, M., & Jialal, I. (2023). Type 2 diabetes. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK513253/

Hong, S. P., Kim, C. Y., & Jung, H. W. (2023). The comparison of the associations of lipoprotein(a) and the atherogenic index of plasma with coronary artery calcification in patients without high LDL-C: A comparative analysis. Journal of Lipid and Atherosclerosis, 12(2), 152–163. https://doi.org/10.12997/jla.2023.12.2.152

International Diabetes Federation. (2025). IDF Diabetes Atlas (11th ed.). International Diabetes Federation. https://diabetesatlas.org

Kim, S. H., Cho, Y. K., Kim, Y. J., Jung, C. H., Lee, W. J., Park, J. Y., Huh, J. H., Kang, J. G., Lee, S. J., & Ihm, S. H. (2022). Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: A nationwide population-based cohort study. Cardiovascular Diabetology, 21, Article 81. https://doi.org/10.1186/s12933-022-01522-8

Lumu, W., Bahendeka, S., Wesonga, R., Kibirige, D., Kasoma, R. M., & Ssendikwanawa, E. (2023). Atherogenic index of plasma and its cardiovascular risk factor correlates among patients with type 2 diabetes in Uganda. African Health Sciences, 23(1), 515–527. https://doi.org/10.4314/ahs.v23i1.54

Vybhavi, V. S. J., Bhavsar, M., Gusani, J., Gohil, Y., Paul, N. K., Garlapati, H. R., & Shrivastava, K. (2025). New insights into the pathophysiology of type 2 diabetes: A review article. Journal of Pharmacy and Bioallied Sciences, 17(Suppl 2), S1070–S1072. https://doi.org/10.4103/jpbs.jpbs_1759_24

Zhao, K., & Ling, S. (2025). Gender-specific association between a novel atherogenic index of plasma, metabolic parameters and inflammation among obese adults. BMC Endocrine Disorders, 25, Article 38. https://doi.org/10.1186/s12902-024-01813-z